Cantor Fitzgerald maintains $25 target on Enovix stock

0 min read | Published on 13 Aug 2026, 06:51 PM |Updated on 13 Aug 2026, 06:51 PM

Reviewed by

Ritika DScanX News Team

Key Highlights

Cantor Fitzgerald analyst Derek Soderberg reaffirmed an Overweight rating on Enovix (ENVX). The brokerage kept its price target at $25, indicating steady sentiment towards the battery technology company without adjusting its valuation outlook.

*this image is generated using AI for illustrative purposes only.

Cantor Fitzgerald analyst Derek Soderberg reiterated an Overweight rating on Enovix (NASDAQ: ENVX) and maintained a $25 price target for the company.

The research note reflects the firm's continued stance on the silicon-anode battery developer.

Analyst Action

Metric	Detail
Rating	Overweight
Price Target	$25
Analyst	Derek Soderberg

Soderberg’s update confirms no change to the previous valuation framework for Enovix. The firm did not disclose specific operational metrics or earnings estimates in this brief update.

How might Enovix's recent progress in silicon-anode battery manufacturing scale impact its ability to meet the $25 price target within the current fiscal year?

What are the key competitive threats from traditional lithium-ion battery manufacturers that could challenge Enovix's market share in the consumer electronics sector?

Could potential partnerships with major smartphone or automotive OEMs serve as a catalyst for Enovix to exceed Cantor Fitzgerald's current valuation framework?

Read Next Article

Enovix Q2 Results: Adj. EPS beats estimate, sales up 21% YoY

1 min read | Published on 13 Aug 2026, 04:45 AM |Updated on 13 Aug 2026, 04:45 AM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Key Highlights

Enovix reported Q2 adjusted EPS of $(0.13), beating the $(0.15) estimate by 13.33%. Sales rose 20.84% YoY to $9.024 million, surpassing the $8.430 million consensus. The flat EPS despite revenue growth suggests improved operational efficiency.

*this image is generated using AI for illustrative purposes only.

Enovix (NASDAQ: ENVX) delivered a stronger-than-expected second-quarter performance, with both top-line revenue and adjusted earnings per share beating analyst estimates. The company reported quarterly sales of $9.024 million, surpassing the consensus forecast of $8.430 million by 7.04%. This represents a 20.84% increase in revenue compared to the $7.468 million recorded in the same period last year.

On the profitability front, Enovix reported an adjusted loss per share of $(0.13), which was narrower than the analyst consensus estimate of $(0.15). This constitutes a beat of 13.33% against expectations. The adjusted EPS figure remained unchanged from the same period in the prior fiscal year, indicating stable per-share loss metrics despite the significant growth in sales volume.

What the Numbers Show

The divergence between the revenue growth and the static adjusted EPS highlights a shift in the company's cost structure or operational leverage during the quarter. While sales expanded by over 20%, the per-share loss did not widen, suggesting that the incremental revenue contributed positively to covering fixed costs or that variable costs scaled efficiently relative to the higher sales volume. The fact that the loss per share remained flat year-over-year while revenue grew significantly indicates improved operational efficiency in converting sales into reduced losses on a per-share basis.

Financial Performance Overview

Metric	Current Quarter	Prior Year Same Period	Change
Sales Revenue	$9.024 million	$7.468 million	+20.84%
Adj. EPS	$(0.13)	$(0.13)	Unchanged
Analyst Estimate (Sales)	$8.430 million	—	Beat by 7.04%
Analyst Estimate (EPS)	$(0.15)	—	Beat by 13.33%

The company’s ability to exceed revenue estimates while maintaining a consistent loss profile suggests that Enovix is successfully scaling its operations without proportionally increasing its per-share financial burden. Investors will likely focus on whether this trajectory can continue to narrow losses further as revenue growth sustains.

Can Enovix sustain its current operational leverage to convert revenue growth into actual profitability in the next two quarters?

How might the company's improved cost structure impact its valuation multiples compared to other pre-profitability battery technology peers?

What specific drivers contributed to the 20.84% year-over-year revenue increase, and are these growth vectors scalable for the remainder of the fiscal year?